Beyond noting accumulations of alpha-synuclein, new research has shed light on other molecular mechanisms by which neurons degenerate in PD, including oxidative stress, alteration of the mitochondria and inflammation. The understanding of these processes has led to new ideas for developing therapies for Parkinson’s.